Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Etanercept Liquid Once Weekly in Active RA
NCT00110903Phase 3Completed
- Sponsor
- Amgen
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00110903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110903.